NRG Oncology/RTOG 0415, hypofractionation in patients with low-risk prostate cancer: are patient reported outcomes the practice change tipping point?

被引：0

作者：

Pugh, Stephanie L. ^{[1
]}

Lee, W. R. ^{[2
]}

Dignam, James ^{[1
]}

Low, Daniel ^{[3
]}

Swanson, Gregory P. ^{[4
]}

Shah, Amit B. ^{[5
]}

D'Souza, David P. ^{[6
]}

Michalski, Jeff M. ^{[7
]}

Dayes, Ian S. ^{[8
]}

Seaward, Samantha A. ^{[9
]}

Nguyen, Paul L. ^{[10
]}

Hall, William A. ^{[11
]}

Pisansky, Thomas M. ^{[12
]}

Chen, Yuhchyau ^{[13
]}

Sandler, Howard M. ^{[14
]}

Movsas, Benjamin ^{[15
]}

Bruner, Deborah W. ^{[16
]}

机构：

[1] NRG Oncol, Philadelphia, PA USA

[2] Duke Univ, Med Ctr, Durham, NC USA

[3] Univ Calif Los Angeles, Los Angeles, CA USA

[4] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA

[5] WellSpan Hlth York Canc Ctr, York, PA USA

[6] London Reg Canc Program, London, ON, Canada

[7] Washington Univ, St Louis, MO USA

[8] McMaster Univ, Juravinski Canc Ctr, Hamilton Hlth Sci, Hamilton, ON, Canada

[9] Kaiser Permanente Northern Calif, Santa Clara, CA USA

[10] Dana Farber Harvard Canc Ctr, Boston, MA USA

[11] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[12] Mayo Clin, Scottsdale, AZ USA

[13] Univ Rochester, Rochester, NY USA

[14] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[15] Henry Ford Hosp, Detroit, MI 48202 USA

[16] Emory Univ, Atlanta, GA 30322 USA

来源：

QUALITY OF LIFE RESEARCH | 2017年 / 26卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

206.2

引用

页码：38 / 39

页数：2

共 50 条

[31] Patient-Reported Long-term Outcomes after Hypofractionated Stereotactic Radiotherapy for Low-risk Prostate Cancer: Evidence from a Prospective Trial
King, C. R.
Brooks, J. D.
Gill, H.
Presti, J. C.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S336 - S336
[32] Does androgen deprivation improve treatment outcomes in patients with low-risk and intermediate-risk prostate cancer?
Hiroshi Miyamoto
Edward M Messing
Chawnshang Chang
Nature Clinical Practice Oncology, 2005, 2 : 236 - 237
[33] Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery
Kachnic, Lisa A.
Winter, Kathryn
Suntharalingam, Mohan
Ilson, David
Konski, Andre
Lloyd, Shane
Mcavoy, Sarah A.
Lad, Thomas
Olowokure, Olugbenga Gbenga
Samson, Pamela
Gore, Elizabeth M.
Meyer, Joshua E.
Videtic, Gregory M. M.
Clump, David A.
Raben, Adam
Kayaleh, Omar
Barker Jr, Jerry
Haddock, Michael G.
Hopkins, Judith O.
Bruner, Deborah W.
QUALITY OF LIFE RESEARCH, 2024, 33 (10) : 2833 - 2844
[34] Patient-Reported Outcomes (PROs) in NRG Oncology/RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Esophageal Cancer Treated Without Surgery
Kachnic, L. A.
Moughan, J.
Suntharalingam, M.
Ilson, D. H.
Konski, A. A.
Burrows, W.
Anker, C.
Bar Ad, V.
Thakrar, H. V.
Hayes, J. P.
Gore, E. M.
Kavadi, V. S.
Komaki, R. U.
Raben, A.
Giguere, J. K.
Pollock, J.
Greenberger, J. S.
Videtic, G. M.
Roof, K. S.
Bruner, D. Watkins
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S31 - S31
[35] Dose Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Suppression for Intermediate Risk Prostate Cancer: Outcomes From the NRG Oncology/RTOG 0815 Randomized Trial
Krauss, D. J.
Karrison, T. G.
Martinez, A. A.
Morton, G.
Yan, D.
Bruner, D. W.
Movsas, B.
Elshaikh, M. A.
Citrin, D. E.
Hershatter, B.
Michalski, J. M.
Efstathiou, J. A.
Currey, A. D.
Kavadi, V. S.
Cury, F.
Lock, M. I.
Raben, A.
Sandler, H. M.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S1 - S1
[36] Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer The NRG Oncology RTOG 0126 Randomized Clinical Trial
Michalski, Jeff M.
Moughan, Jennifer
Purdy, James
Bosch, Walter
Bruner, Deborah W.
Bahary, Jean-Paul
Lau, Harold
Duclos, Marie
Parliament, Matthew
Morton, Gerard
Hamstra, Daniel
Seider, Michael
Lock, Michael I.
Patel, Malti
Gay, Hiram
Vigneault, Eric
Winter, Kathryn
Sandler, Howard
JAMA ONCOLOGY, 2018, 4 (06)
[37] CLINICAL OUTCOMES OF PATIENTS ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER WITH SMALL INDEX LESIONS ON MRI
Jayant, Siva
Neil, Mendhiratta
William, Azar
Sahil, Parikh
Kyle, Schuppe
Alexander, Kenigsberg P.
Christopher, Koller
Charles, Hesswani
Maria, Merino
Bradford, Wood J.
Baris, Turkbey
Sandeep, Gurram
Peter, Pinto A.
Anjali, Pillai
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S15 - S15
[38] CONVENTIONAL VERSUS HYPOFRACTIONATION RADIATION FOR HIGH RISK PROSTATE CANCER PATIENTS (CHIRP): 24 MONTHS PATIENT-REPORTED QUALITY OF LIFE OUTCOMES OF THE RANDOMIZED PHASE II CHIRP TRIAL
Yang, Fan
Ghosh, Sunita
Yee, Don
Patel, Samir
Parliament, Matthew
Usmani, Nawaid
Danielson, Brita
Amanie, John
Pearcey, Robert
Pederson, John
Dundas, George
Field, Colin
Fallone, Gino
Murtha, Albert
RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S16 - S17
[39] Does Race Affect Postoperative Outcomes in Patients With Low-Risk Prostate Cancer Who Undergo Radical Prostatectomy?
Resnick, M. J.
Canter, D. J.
Guzzo, T. J.
Brucker, B. M.
Bergey, M.
Sonnad, S. S.
Wein, A. J.
Malkowicz, S. B.
UROLOGY, 2009, 73 (03) : 620 - 623
[40] Toxicity Index, Patient-Reported Outcomes, and Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35
Henry, N. Lynn
Kim, Sungjin
Hays, Ron D.
Diniz, Marcio A.
Luu, Michael
Cecchini, Reena S.
Yothers, Greg
Rogatko, Andre
Ganz, Patricia A.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (34) : 3800 - +

← 1 2 3 4 5 →